Last update 11 Jul 2024
Actelion Pharmaceuticals Ltd.

Actelion Pharmaceuticals Ltd.

Subsidiary Company|
1997|
Switzerland
|
5,000-10,000
| SWX: ATLN|

Overview

Basic Info

Introduction
Actelion Ltd is a biopharmaceutical corporation that specializes in the research, development, and commercialization of low molecular weight drugs for a variety of medical conditions. The company's primary products include Tracleer, an orally administered dual endothelin receptor antagonist used to treat pulmonary arterial hypertension, a life-threatening disorder that affects the heart and lungs. Additionally, Actelion offers Zavesca, an oral medication for adult patients with mild to moderate type 1 Gaucher disease, and Ventavis, an inhaled synthetic analogue of prostacyclin. The company is also involved in the clinical development of various compounds for the treatment of cardiovascular, cardiopulmonary, immunological, infectious diseases, metabolic disorders, and central nervous system disorders. Actelion has a global alliance with Merck & Co, Inc. to discover, develop, and market new classes of renin inhibitors for patients with cardio-renal diseases. The company was established in 1997 and is headquartered in Allschwil, Switzerland.

Tags

Other Diseases
Respiratory Diseases
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug8
Unknown1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 1 Clinical
Phase 2 Clinical
1
1
Phase 3 Clinical
Approved
5
22
Other
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free